Albert David Limited (BOM:524075)

India flag India · Delayed Price · Currency is INR
649.95
+9.65 (1.51%)
At close: Mar 25, 2026
Market Cap3.47B -26.1%
Revenue (ttm)3.23B -10.4%
Net Income96.12M -76.2%
EPS16.84 -76.2%
Shares Out5.71M
PE Ratio36.09
Forward PEn/a
Dividend5.00 (0.77%)
Ex-Dividend DateJul 25, 2025
Volume1,274
Average Volume594
Open652.50
Previous Close640.30
Day's Range645.55 - 665.65
52-Week Range601.00 - 959.35
Beta-0.07
RSI28.60
Earnings DateMay 13, 2026

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1938
Employees 1,805
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524075
Full Company Profile

Financial Performance

In fiscal year 2025, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.

Financial Statements